Publicacions en col·laboració amb investigadors/es de Hospital Universitario San Cecilio (24)

2024

  1. COVID-19 and Pregnancy: A Dangerous Mix for Bone Turnover and Metabolism Biomarkers in Placenta and Colostrum

    Journal of Clinical Medicine, Vol. 13, Núm. 7

  2. Comparison of different methods of first-trimester screening for preterm pre-eclampsia: cohort study

    Ultrasound in Obstetrics and Gynecology, Vol. 64, Núm. 1, pp. 57-64

  3. Validation of machine-learning model for first-trimester prediction of pre-eclampsia using cohort from PREVAL study

    Ultrasound in Obstetrics and Gynecology, Vol. 63, Núm. 1, pp. 68-74

2023

  1. Performance of first-trimester combined screening for preterm pre-eclampsia: findings from cohort of 10 110 pregnancies in Spain

    Ultrasound in Obstetrics and Gynecology, Vol. 62, Núm. 4, pp. 522-530

2022

  1. COVID‐19 during Gestation: Maternal Implications of Evoked Oxidative Stress and Iron Metabolism Impairment

    Antioxidants, Vol. 11, Núm. 2

  2. Risk of fetal loss after chorionic villus sampling in twin pregnancy derived from propensity score matching analysis

    Ultrasound in Obstetrics and Gynecology, Vol. 59, Núm. 2, pp. 162-168

2021

  1. Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial

    American Journal of Obstetrics and Gynecology, Vol. 224, Núm. 1, pp. 86.e1-86.e19

  2. Fetal loss after chorionic villus sampling in twin pregnancy

    Ultrasound in Obstetrics and Gynecology, Vol. 58, Núm. 1, pp. 48-55

  3. Three-dimensional ultrasonography for advanced neurosonography (neurosofe-3D): Validation of a brain volume acquisition guideline

    Acta Obstetricia et Gynecologica Scandinavica, Vol. 100, Núm. 1, pp. 84-90

2020

  1. New approach for estimating risk of miscarriage after chorionic villus sampling

    Ultrasound in Obstetrics and Gynecology, Vol. 56, Núm. 5, pp. 656-663

2018

  1. Aspirin Versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia

    Obstetrical and Gynecological Survey

  2. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit

    American Journal of Obstetrics and Gynecology, Vol. 218, Núm. 6, pp. 612.e1-612.e6

  3. Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE

    Ultrasound in Obstetrics and Gynecology, Vol. 52, Núm. 1, pp. 52-59

2017

  1. ASPRE trial: performance of screening for preterm pre-eclampsia

    Ultrasound in Obstetrics and Gynecology, Vol. 50, Núm. 4, pp. 492-495

  2. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation

    Ultrasound in Obstetrics and Gynecology, Vol. 49, Núm. 6, pp. 751-755

  3. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia

    New England Journal of Medicine, Vol. 377, Núm. 7, pp. 613-622

  4. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations

    Ultrasound in Obstetrics and Gynecology, Vol. 49, Núm. 6, pp. 756-760

2016

  1. Gender specific differences in oxidative stress and inflammatory signaling in healthy term neonates and their mothers

    Pediatric Research, Vol. 80, Núm. 4, pp. 595-601

  2. Three dimensional ultrasonography for advanced neurosonography (Neurosofe-3d). Analysis of acquisition-related factors influencing the quality of the brain volumes

    Prenatal Diagnosis, Vol. 36, Núm. 11, pp. 1054-1060

2015

  1. A new approach to oxidative stress and inflammatory signaling during labour in healthy mothers and neonates

    Oxidative Medicine and Cellular Longevity, Vol. 2015